根据ACC/AHA病变分类,针对急性心肌梗塞进行血管内成像指导的皮肤冠状动脉干预
Sang Yoon Lee1, Hyun Sung Joh2, Hyun Kuk Kim3
1Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Revista espanola de cardiologia (English ed.)
|December 6, 2025
概括
血管内成像 (IVI) 引导的穿皮冠状动脉干预 (PCI) 在急性心肌梗塞 (AMI) 患者中减少了严重的不良心脏事件 (MACE) 复杂的 (B2/C) 病变. 在更简单的 (A/B1) 病变中没有观察到这种益处,这表明病变复杂性增加的价值.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗成像医学成像
背景情况:
- 血管内成像 (IVI) 指导改善了复杂冠状动脉病变的皮肤冠状动脉干预 (PCI) 结果.
- 它对急性心肌梗塞 (AMI) 患者的益处,根据ACC/AHA病变分类进行分层,仍然不确定.
研究的目的:
- 评估IVI引导PCI与血管学引导PCI在AMI患者不同ACC/AHA病变复杂性的临床益处.
- 确定IVI指导是否基于心脏病发作相关的动脉损伤特征提供预后优势.
主要方法:
- 对2个韩国AMI注册表 (KAMIR-V,KAMIR-NIH) 的综合分析,其中包括23051名接受PCI成功的患者.
- 患者根据ACC/AHA病变分类进行了分层 (A/B1型与A/B1型对比). 类型B2/C). 这样就好了.
- 在IVI指导和血管学指导的PCI组之间对三年主要不良心脏事件 (MACE) 的比较.
主要成果:
- 在IVI指导的PCI中,在患有B2/C型病变的患者中,MACE的发病率显著降低 (调整HR,0.78;P<.001).
- 在IVI引导和血管学引导的PCI之间没有观察到MACE的显著差异,用于A/B1型病变 (调整HR,0.81;P = .190).
- 这种模式适用于非ST段升高心肌梗塞和ST段升高心肌梗塞子组.
结论:
- 在AMI患者中,IVI引导的PCI与复杂的冠状动脉病变 (B2/C型) 的MACE降低有关.
- 以IVI为指导的PCI的预后益处取决于病变的复杂性,随着复杂性的增加而增加.
- 在AMI患者中,血管造影引导的PCI可能足以治疗更简单的 (A/B1型) 病变.
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
736
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
736
01:28Acute Coronary Syndrome IV: Interprofessional Care
200
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
200
01:30Acute Coronary Syndrome III: Diagnostic Studies
199
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
199
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
325
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
325
01:27Coronary Artery Disease V: Interprofessional Care
205
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
205
01:28Cardiac Catheterization I: Pre-Procedure Overview
997
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
997